Raised tHcy as a risk factor for retinal vascular occlusive disease. Distribution of risk factors for cardiovascular and retinal vascular occlusive disease
| Controls | Cases | |||||
|---|---|---|---|---|---|---|
| All | Arterial | All vein | Central vein | Branch vein | ||
| No of subjects | 87 | 87 | 26 | 61 | 40 | 21 |
| Lipid lowering therapy (%) | 4.6 | 6.9 | 1.5 | 4.9 | 7.5 | 0.0 |
| p Value | 0.744 | 0.197 | 1.00 | 0.677 | 1.00 | |
| Treatment for hypertension (%) | 36.8 | 58.6 | 69.2 | 54.1 | 52.5 | 57.1 |
| p Value | 0.006 | 0.007 | 0.037 | 0.140 | 0.145 | |
| Current smokers (%) | 32.2 | 17.2 | 19.2 | 16.4 | 15.0 | 19.0 |
| p Value | 0.035 | 0.303 | 0.048 | 0.069 | 0.359 | |
| Diabetes mellitus (%) | 8.0 | 11.5 | 15.4 | 9.8 | 5.0 | 19.0 |
| p Value | 0.669 | 0.273 | 0.933 | 0.718 | 0.218 | |
| Ischaemic heart disease (%) | 16.1 | 23.0 | 27.0 | 21.3 | 27.5 | 9.5 |
| p Value | 0.339 | 0.252 | 0.553 | 0.207 | 0.732 | |
| Previous carotid endarterectomy (%) | 0.0 | 6.9 | 19.2 | 1.6 | 0.0 | 4.7 |
| p Value | 0.028 | 0.0004 | 0.416 | 1.00 | 0.201 | |
| Previous TIA/CVA (%) | 4.6 | 12.6 | 15.4 | 11.5 | 12.5 | 9.5 |
| p Value | 0.105 | 0.080 | 0.201 | 0.138 | 0.330 | |
| Treatment for glaucoma (%) | 10.0 | 17.0 | 4.0 | 23.0 | 22.5 | 19.0 |
| p Value | 0.11 | 0.411 | 0.020 | 0.046 | 0.13 | |